Data / Crowdfunding / Massachusetts / Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc.: crowdfunding raise on StartEngine Primary, LLC, $19,999 to $4,999,999 (2026)
Oxeia Biopharmaceuticals, Inc., a corporation in Boston, MA, filed a Form C with the SEC on September 21, 2026 to raise $19,999 to $4,999,999 in Series CF Preferred Stock through StartEngine Primary, LLC. The offering closed on September 24, 2026. In its most recent fiscal year it reported $0 in revenue and a net loss of $1,246,701, with 2 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- www.oxeiabiopharma.com
- Funding portal
- StartEngine Primary, LLC
- Address
- 361 NEWBURY STREET SUITE 500, Boston, MA 02115
- Legal form
- Corporation
- Jurisdiction
- DE
- Incorporated
- March 19, 2014
- SEC CIK
- 0001610315
Offering terms
From the amendment filed September 21, 2026.
- Security
- Series CF Preferred Stock
- Price
- $0.79
- Target
- $19,999
- Maximum
- $4,999,999
- Deadline
- September 24, 2026
- Portal compensation
- 7 - 13 percent
Financials
From the Form C-U filed September 28, 2026.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $0 | $0 | sec.gov |
| Cost of goods sold | $0 | $0 | sec.gov |
| Net income | $-1,246,701 | $-1,053,814 | sec.gov |
| Taxes paid | $0 | $0 | sec.gov |
| Total assets | $260,456 | $213,921 | sec.gov |
| Cash | $2,905 | $25,477 | sec.gov |
| Accounts receivable | $0 | $0 | sec.gov |
| Short-term debt | $12,676,450 | $7,951,988 | sec.gov |
| Long-term debt | $0 | $3,897,661 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| September 28, 2026 | Progress update | $19,999 | $4,999,999 | September 24, 2026 | At the close of the offering, the issuer closed on $1,806,154.09 and 2,910,643 number of securities. | sec.gov |
| September 21, 2026 | Amendment | $19,999 | $4,999,999 | September 24, 2026 | Correction to typo in loyalty perk | sec.gov |
| August 14, 2026 | Amendment | $19,999 | $4,999,999 | September 24, 2026 | Moving up the campaign end date to September 24, 2026 and adding a header change | sec.gov |
| July 21, 2026 | Amendment | $19,999 | $4,999,999 | November 4, 2026 | Changing Flash Perk 4 Start Date to Begin on Day 198 July 21st | sec.gov |
| May 26, 2026 | Amendment | $19,999 | $4,999,999 | November 4, 2026 | Extending campaign end date and adding flash perks | sec.gov |
| April 3, 2026 | Amendment | $19,999 | $4,999,999 | July 6, 2026 | Exhibit image size fix | sec.gov |
| April 2, 2026 | Amendment | $19,999 | $4,999,999 | July 6, 2026 | Increasing Funding Goal, Updating Form C financial information section 2025 and 2024 Audit, and Extending Campaign End Date | sec.gov |
| January 15, 2026 | Amendment | $19,999 | $1,234,999 | April 6, 2026 | Update to Campaign Page | sec.gov |
| January 5, 2026 | Offering | $19,999 | $1,234,999 | April 6, 2026 | sec.gov |
Updated September 28, 2026. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.